Alex Harding

Alex Harding

Corporate Officer/Principal at CRISPR THERAPEUTICS AG

Consumer Services
Health Technology
Finance

Profile

Alex Harding is currently the Head of Business Development and Senior Vice President at CRISPR Therapeutics AG since 2023.
Prior to this, he worked as an Associate at Atlas Venture Advisors, Inc. from 2018 to 2019.
He also held the position of Senior Vice President of Business Development at Remix Therapeutics, Inc. Dr. Harding completed his Doctorate degree from The Johns Hopkins University in 2015, his Undergraduate degree from Yale University in 2014, and his MBA from Harvard Business School in 2014.

Alex Harding active positions

CompaniesPositionStart
CRISPR THERAPEUTICS AG Corporate Officer/Principal 2023-01-04
All active positions of Alex Harding

Former positions of Alex Harding

CompaniesPositionEnd
Private Equity Analyst 2019-12-30
Corporate Officer/Principal -
See the detail of Alex Harding's experience

Training of Alex Harding

The Johns Hopkins University Doctorate Degree
Yale University Undergraduate Degree
Harvard Business School Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Alex Harding's experience

Connections

100 +

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
CRISPR THERAPEUTICS AG

Health Technology

Private companies2

Finance

Health Technology

See company connections